Lindsay Corporation's Board authorized a $150 million share repurchase program on November 3, 2025, marking the first new buyback authorization for the irrigation equipment maker in several years. The company trades at approximately $1.2 billion market capitalization, making this authorization roughly 12.5% of float—a meaningful signal in the capital-light agricultural technology sector.
Lindsay manufactures center-pivot and lateral-move irrigation systems under the Zimmatic brand, plus road safety equipment through its infrastructure division. The authorization arrives as North American farm equipment demand stabilizes after two years of inventory correction. The company generated $178 million in operating cash flow over the trailing twelve months, with net debt sitting near $85 million—conservative leverage for a cyclical industrial. Management has not disclosed execution timeline or price parameters, leaving the market to infer urgency from quarterly 10-Q filings starting February 2026.
The timing matters. Lindsay's irrigation revenue declined 18% year-over-year in the most recent quarter as farmers delayed capital purchases amid compressed grain margins. But soil moisture data from the USDA's October report showed the driest conditions in the Central Plains since 2018, historically a leading indicator for irrigation system orders with a six-to-nine-month lag. Competitors like Valmont Industries have seen order inquiries rise 22% sequentially, suggesting the trough passed in Q3. A buyback now—rather than waiting for revenue recovery—indicates management sees the stock materially below intrinsic value, or expects leverage metrics to deteriorate if they sit on cash through an upcycle.
The authorization also removes a hangover. Lindsay's last program, a $50 million authorization from 2019, was exhausted by early 2021 and never replaced, leaving the company without a buyback framework through the entire post-pandemic commodity surge. That absence raised questions among allocators about capital discipline, particularly as peers returned 40-60% of free cash flow to shareholders during the same window. This $150 million program—triple the prior size—resets that narrative and gives management flexibility to offset dilution from equity compensation, which ran 1.8% of shares outstanding annually over the past three years.
Watch for initial purchases in the December quarter, disclosed via Form 4 filings and the February 10-Q. Management typically executes $8-12 million per quarter when active, implying this program runs 12-18 months if deployed steadily. Also watch infrastructure division margins; that segment posted 14.2% EBIT last quarter, up from 11% a year prior, and generates the predictable cash flow that funds opportunistic equity purchases. If execution accelerates beyond $15 million quarterly, it signals management sees the stock dislocated, not just fairly valued.
Lindsay has not bought back stock since Q4 2022. The Board's move breaks that drought the quarter after an 11% share price decline, with the stock now trading at 1.1x tangible book value—near the lower end of its five-year range despite improved balance sheet positioning and a likely inflection in end-market demand by mid-2026.